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SUMMARY
Introduction Calcium phosphates are chemical compounds that can be found in various forms within nature, as well 
as in human jaws and bones. The aim of this study was to assess the structure of solid chemical compounds which 
form the structure of normal and osteoporotic jaw-bones.
Materials and Methods The jaw-bones taken from human cadavers were used in the study. Crystalographic forms 
of calcium phosphate, in the samples of human jaw-bone, were determined using X-ray diffraction technique. The 
experimental bone samples originated from osteoporotic jaw-bone of cadavers while control samples were taken 
from dentate jaw-bones of non-osteoporotic cadavers.
Results The results of this study showed that hydroxyapatite was the only phase determined in control non-osteopo-
rotic bone samples. In experimental (osteoporotic) bone samples, the same phase was registered, as well as calcium 
monophosphate and hydrated calcium phosphate, registered as increments of values on α axis.
Conclusion Hydroxyapatite was the only compound detected in normal bone while osteoporotic bone contained 
others crystallographic forms of calcium phosphates.
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INTRODUCTION
Calcium orthophosphates are important compounds that 
form the structure of bone [1, 2]. These compounds are 
materialized in various forms in nature, but in human 
bones and jaws the most important are: hydroxyapa-
tite (HAP), with molecular formula Ca10(PO4)6(OH)2 (as 
well as: Ca5(PO4)3(OH)), calcium monophosphate (M), 
with formula CaHPO4, monoclinic, and hydrated calcium 
phosphate (B), with formula CaHPO4×2H2O, three-clinic. 
Besides, it has been considered that amorphous phases of 
calcium phosphate are most frequently registered form 
in nature [3, 4].
The coefficients of solubility (L) of calcium phosphate 
compounds are different at the temperature of 37°C and 
are as following: L=9.2×10-7 for calcium monophos-
phate, L=1.87×10-7 for hydrated calcium phosphate, and 
L=5.5×10-118 for HAP [1]. However, some other sources 
suggest the different value for the coefficient of solubil-
ity of HAP: L=2.27×10-58 at 37°C [5]. Hydrated calcium 
phosphate was obtained by mixing the solutions of CaCl2 
(0.01-0.08 mol/l) and NaHPO4×H2O (0.005-0.08 mol/l), 
at pH<7.1, and the temperature of 25°C. Additionally, at 
pH=7.1 and higher, the amorphous sediment of calcium 
phosphate takes over and the ratio becomes Ca:P=1.47. 
In the mixture of the calcium hydroxide suspension and 
orthophosphoric acid solution, the five consecutive levels 
of the reaction could be indentified, previously formed 
HAP is transformed to hydrated calcium phosphate with 
the coefficient of solubility in function of the temper-
ature of L= e (8403/Т + 41.8-0.97 T) [6]. At 37°C and 
pH=6, the rate of hydrated calcium phosphate forma-
tion is more than 1000 times higher than formation of 
HAP. In water solution with initial pH=10.8, the tempera-
ture of 39°C and prolonged period of hydrolysis, hydrated 
calcium phosphate is transformed to HAP deficient in 
calcium [7]. However, extended duration of hydrolysis 
can be useful for transformation to normal HAP. Addition 
of Ca++ ions accelerates the formation of HAP. That way, 
the amorphous calcium phosphate plays the important 
role in the processes of calcium phosphate formation [8]. 
The synthetic HAP, used in the production of artificial 
bone substitution, has different structure as compared 
to the natural HAP and it is in vivo changed by mechan-
ical crushing and meshing of the particles. To be useful 
in practice, it should be processed by temperature [9]. 
Many chemical compounds that consist of calcium phos-
phates only, are used in fabrication of orthopedic and 
dental cements [10]. Strictly defined relationship of wet 
and dry particles, as well as the dimension of particles is 
the most important for HAP fabrication [11].
Human bone consists of different chemical compounds. 
The content, as well as the structure of solid phase has 
influence on macro-appearance and bone strength. 
However, some of solid compounds could be transformed 
into bones, as showed by stoichiometric HAP (CaO/P2O5), 
HAP, calcium monophosphate and hydrated calcium phos-
phate [1-4, 8, 11-15].
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The aim of this study was to assess the types of solid 
compounds that form the structure and composition of 
normal and osteoporotic human bone.
MATERIALS AND METHODS
The jaw-bones taken from cadavers were used in the 
study. Two groups of samples were formed (experimen-
tal and control). Experimental samples (E) were taken 
from osteoporotic bone while controls were the samples 
that originated from normal bone (C). Each of the bone 
samples was carefully extracted from jaw bones using 
diamond bur and diamond disc. The samples of bone 
were extracted from two different bone layers– basal layer 
with the compact structure, and spongy layer from alveo-
lar ridge, close to the mental foramen (for mandible). All 
of the samples had similar dimensions (1×1×1 cm) and 
were prismatic in shape. In order to prepare for exami-
nation, the samples were separated, isolated, cleaned and 
degreased in the acetone [13, 14, 16-19]. After drying and 
storage in vacuum conditions, samples were mechanically 
dusted in ahat mortar.
Roentgen diffractograms of experimental and control 
samples of bone were recorded in diffractometer (Crystal-
loflex diffractometer D-500, Siemens). Electric power of 
35 kV and 20 mA was used for the experiment. Powder 
mixture was placed in diffractometer in order to detect 
the phases and compounds in bone samples. Diagrams of 
dusts were recorded in the area of 3° to 121°. From each 
of diffractograms intensities (I) and angles of 2Θ were 
de termined. Values of angles of diffraction were calcu-
lated according to the formula: α=λ/2sinΘ, where α is the 
distance of mesh of planes of Muler’s index, λ the X-ray 
wavelength, and Θ the angle between the X-ray beam and 
parallel planes.
RESULTS
X-ray diffraction was used to analyze the mineral content 
of bone samples. Different parameters are shown as 
Table 1. Composition of jaw-bone layers
Tabela 1. Sastav slojeva vilične kosti
Sample
Uzorak
Roendgen spectrum bands*
Rendgenske trake i spektri*
Crystal phase
Kristalna faza
Molecular formula
Hemijska formula
E1
1a, 1b, 1c, 1d, 1e, 1f, 1g HydroxyapatiteHidroksiapatit Ca10(PO4)6  (OH)2
2a, 2b Calcium monophosphateKalcijum-monofosfat CaHPO4
3a, 3b, 3c Hydrated calcium phosphateHidratisani kalcijum-fosfat CaHPO4×2H2O
4 Tetracalcium phosphateTetrakalcijum-fosfat Ca4P2O9
E2
1a, 1b, 1c, 1d, 1e, 1f, 1g, 1h, 1i Unstable phase of hydroxyapatiteNestabilna faza hidroksiapatita Ca10(PO4)6×(OH)2
2a, 2b Calcium monophosphateKalcijum-monofosfat CaHPO4
C1, C2 1a, 1b, 1c, 1d, 1e, 1f, 1g, 1h, 1i
Unstable phase of hydroxyapatite
Nestabilna faza hidroksiapatita Ca10(PO4)6×(OH)2
* according to notation in the corresponding spectrum
* u skladu s nalazom odgovarajućeg spektra
Figure 1. Diffractogram represents the inorganic constituents of micro-
crystals in powder made from spongy bone of experimental jaw
Slika 1. Difraktogram koji predstavlja neorganski sastav mikrokristala 
u naprašenom uzorku spongioze eksperimentalnog uzorka kosti
Figure 2. Diffractogram of exterior layer of experimental bone
Slika 2. Difraktogram koji predstavlja neorganski sastav spoljašnjeg 
sloja eksperimentalnog uzorka kosti
increments of values on α-axis while the value of c-axis 
remained the same.
Results of the study are shown on Table 1 and Figures 
1, 2, and 3. Diffractogram of the sample C1 was identi-
cal in structure as diffractogram of the sample C2. The 
forms of crystals in assessed samples were determined 
on the basis of roentgen bands position in the spectrum 
[15, 16, 20], with particular focus to their stoichiometric 
structure (Table 1).
 Ca5(PO4)3OH; * CaHPO4;  CaHPO4×2H2O; ◊ Ca4P2O9
 Ca5(PO4)3OH; * CaHPO4
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Obtained results showed that HAP was the domi-
nant phase in the samples C1 and C2, while the bands of 
other phases were not present or their concentration was 
undetectable. In the sample E1, calcium phosphates M 
and B were present in equal amounts as HAP, which was 
confirmed by increasing values on the α-axis, within range 
20 to 40. In the sample E2 HAP and calcium monophos-
phate were present, with concentrated calcium monophos-
phate at the value 20 and higher on α-axis.
DISCUSSION
Diffraction is reliable and proven method to determine 
calcium phosphates in crystals and bone structure, cements 
and transplants for dental, craniofacial and orthopedic 
application. By this method, an alignment of spectrum 
crystals can be visualized, as confirmed in the current 
study. Diffraction can show intermediary compounds 
also, if present in calcium’s crystals in bone, with or with-
out added biometric molecules [14, 21, 22, 23]. Very inter-
esting finding from the current study was intermediary 
compound tetra calcium phosphate (Ca4P2O9), because of 
its possible involvement in chemical reactions for trans-
plant bonding to osteoporotic bone. This intermediary 
chemical compound was generated at the temperature of 
1200°C, when diffractogram showed apparition of tetra 
calcium phosphate during sintering of artificial HAP [24]. 
Beside the bone structure, diffraction can show crystal 
structure of other hard tissues (for example, enamel and 
dentin) [17], as well as the dimensions of crystal phase in 
chemical compound of calcium (HAP) [23, 25].
The results of the study indicated the existence of solid 
chemical compounds in osteoporotic bone. In regard to 
chemical analysis, osteoporosis is the process of forma-
tion some other crystal forms of calcium phosphate, 
calcium monophosphate and HAP, before all. Respecting 
the medium in which that kind of process exists, a physio-
logic and biochemical processes in human organism might 
be responsible. Also, the intensive changes in equilibrium 
conditions, such as pH of the medium, without deficiency 
of calcium or phosphorus in human body could be the 
important factor [5, 6]. However, the ratio of calcium to 
phosphorous in determined compounds, as indicated in 
Table 1, points to the fact that the deficiency of Ca++ in 
physiologic medium might initiate recrystalization, i.e. 
from HAP where Ca:P ratio is 5:3 (in the samples E1 and 
E2) to generate calcium monophosphate, the compound 
wherein the calcium to phosphorus ratio is equal (1:1). 
That way, the crystallography structure has been changed, 
as well as some other characteristics of solid phase. On the 
basis of that finding, it could be discussed that the reduc-
tion of calcium content in the solution or physiologic envi-
ronment can influence the transition of HAP to calcium 
monophosphate, or hydrated calcium phosphate. Also, the 
formation of Ca++ stable complexes with other inorganic 
or organic compounds could be the cause of HAP trans-
formation into different crystal forms.
It is the fact that these kinds of studies using human 
samples of hard tissue are rare in national as well as inter-
national literature. The method of x-ray diffraction is reli-
able for assessing crystal structure and inorganic compo-
nents of bone in the analysis of oral hard tissues as well as 
the other tissues of human origin [14, 17].
CONCLUSION
On the basis of rentgenographic analysis, the crystallo-
graphic forms of calcium phosphates M, B, as well as HAP 
were detected in osteoporotic samples. In the control bone 
samples HAP was the only compound present.
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KRATAK SADRŽAJ
Uvod Je di nje nja kal ci jum-fos fa ta se u pri ro di na la ze u raz li či tim ob li ci ma, a mo gu se na ći i u vi li ca ma i ko sti ma kod lju di. Cilj ovog 
ra da je bio da se pro ve ri sa stav čvr stih he mij skih je di nje nja ko ja či ne struk tu ru nor mal ne i ko sti vi li ca za hva će ne oste o po ro zom.
Ma te ri jal i me to de ra da Kao ma te ri jal u is tra ži va nju ko ri šće ne su vi li ce ka da ve ra. Kri sta lo graf ski ob li ci kal ci jum-fos fa ta u ko sti ma 
vi li ca od re đe ni su me to dom di frak ci je rend gen skim zra ci ma. Eks pe ri men tal ni uzor ci ko sti ju su iz dvo je ni iz be zu bih oste o po ro znih 
vi li ca, a kon trol ni uzor ci iz ozu blje nih vi li ca bez oste o po ro ze.
Re zul ta ti Do bi je ni re zul ta ti su po ka za li da je hi drok si a pa tit je di na kri stal na fa za u kon trol nim uzor ci ma vi li ca. U uzor ci ma vi li-
ca s oste o po ro zom, po red na ve de ne fa ze, uoče ni su i kal ci jum-mo no fos fat i hi dra ti sa ni kal ci jum-fos fat kod po ve ća nja vred no sti 
na alfa osi.
Za klju čak Kod nor mal ne ko sti za stu pljen je sa mo hi drok si a pa tit, dok se kod ko sti za hva ćene oste o po ro zom ja vlja ju i dru gi kri sta-
lo graf ski ob li ci kal ci jum-fos fa ta.
Ključ ne re či: di frak ci ja; mi kro kri sta li; mi ne ral ni sa stav ko sti; vi li ca
UVOD
Kal ci jum-or to fos fa ti su zna čaj na je di nje nja ko ja uče stvu ju u for-
mi ra nju struk tu re ko sti [1, 2]. Ova je di nje nja se u pri ro di na la ze 
u raz li či tim ob li ci ma, ali su u ko sti ma i vi li ca ma lju di naj va žni ji 
hi drok si a pa tit (HAP), či ja je he mij ska for mu la Ca10(PO4)6(OH)2 
(ne gde i: Ca5(PO4)3(OH)), kal ci jum-mo no fos fat (M), či ja je he-
mij ska for mu la CaH PO4, i hi dra ti sa ni kal ci jum-fos fat (B), od no-
sno kal ci jum po lu hi drat, či ja je he mij ska for mu la CaH PO4×2H2O. 
Sma tra se da je amorf ni ob lik kal ci jum-fos fa ta i naj če šći he mij-
ski ob lik u pri ro di [3, 4].
Ko e fi ci jent ras tvor lji vo sti (L) za je di nje nja kal ci jum-fos fa-
ta je raz li čit na tem pe ra tu ri od 37°C: 9,2×10-7 za kal ci jum-mo-
no fos fat, 1,87×10-7 za kal ci jum-po lu hi drat i 5,5×10-118 za HAP 
[1]. Me đu tim, pre ma ne kim na uč nim iz vo ri ma, ko e fi ci jent ras-
tvor lji vo sti HAP je dru ga či ji od pr vo bit no utvr đe nog i iz no si 
2,27×10-58 pri tem pe ra tu ri od 37°C [5]. Hi dra ti sa ni kal ci jum-
fos fat je do bi jen me ša njem ras tvo ra CaCl2 (0,01-0,08 mol/l) i 
NaH PO4×H2O (0,005-0,08 mol/l) pri vred no sti pH ma njoj od 
7,1 i tem pe ra tu ri od 25°C. Ipak, pri vred no sti pH od 7,1 i ve-
ćim, amorf ni se di ment kal ci jum-fos fa ta po či nje da pre o vla da-
va, pri če mu se od nos kal ci ju ma i fos fo ra me nja u Ca:P=1,47. 
U slo že noj su spen zi ji kal ci jum-hi drok si da s ras tvo rom or to-
fos for ne ki se li ne mo že se ja vi ti pet ni voa re ak ci je, pri če mu 
se pret hod no stvo re ni HAP tran sfor mi še u hi drat kal ci jum-
fos fa ta s ko e fi ci jen tom ras tvor lji vo sti u funk ci ji tem pe ra tu re 
od L=e(8403/Т + 41,8-0,97 T) [6]. Pri tem pe ra tu ri od 37°C i 
vred no sti pH od 6, ste pen for mi ra nja hi dra ta kal ci jum-fos fa ta 
je vi še od hi lja du pu ta ve ći u od no su na je di nje nje HAP. U vo-
de nom ras tvo ru s po čet nom vred no šću pH od 10,8 i pri tem-
pe ra tu ri od 39°C, po sle pro du že nog pe ri o da hi dro li ze, hi drat 
kal ci jum-fos fa ta se tran sfor mi še u HAP u ko jem je kal ci jum 
de fi ci ta ran [7]. Me đu tim, pro du že no tra ja nje pro ce sa hi dro li-
ze mo že uti ca ti na stva ra nje HAP u ko jem je kal ci jum pra vil no 
za stu pljen. Do da tak kal ci ju ma (Ca++ jo na) ubr za va stva ra nje 
HAP. Na ovaj na čin, amorf ni kal ci jum-fos fat ima va žnu ulo gu 
u pro ce su stva ra nja kal ci jum-fos fa ta [8]. Sin te ti sa ni HAP, ko-
ji se ko ri sti za stva ra nje ve štač kih za me ni ka ko sti, dru ga či je je 
struk tu re od pri rod nog HAP, ko ji je u uslo vi ma in vi vo iz me-
njen zbog me ha nič kih de lo va nja i ra se ja va nja par ti ku la i ko ji bi 
se, zbog pri me ne, mo rao do dat no ter mič ki ob ra di ti [9]. Mno-
ga he mij ska je di nje nja ko ja se sa sto je uglav nom od kal ci jum-
fos fa ta pri me nju ju se u pro iz vod nji ve štač kih ce men ta u or to-
ped skoj hi rur gi ji i in du stri ji den tal nih ce men ta [10]. U pro iz-
vod nji HAP ve o ma je zna ča jan tač no utvr đen od nos vla žnih i 
su vih če sti ca, kao i di men zi ja če sti ca [11].
Ljud ska kost se sa sto ji od raz li či tih he mij skih je di nje nja. Sa-
dr žaj i struk tu ra čvr ste fa ze uti ču na ma kro pri kaz i ja či nu ko-
sti. Ipak, po je di na je di nje nja se mo gu iz me ni ti u ko sti, na šta 
uka zu ju opi si sto i hi o me trij skog HAP (CaO/P2O5), HAP, kal ci-
jum-mo no fos fa ta i hi dra ti sa nog kal ci jum-fos fa ta [1-4, 8, 11-15].
Cilj ovog ra da je bio da se utvr de čvr sta he mij ska je di nje nja 
ko ja či ne struk tu ru i ula ze u sa stav nor mal ne i ko sti ljud skih 
vi li ca za hva će ne oste o po ro zom.
MATERIJAL I METODE RADA
Kao ma te ri jal u is tra ži va nju ko ri šće ne su vi lič ne ko sti ka da ve-
ra. Eks pe ri ment je vr šen na dve gru pe uzo ra ka. Eks pe ri men-
tal ni uzor ci (E) su iz dvo je ni iz ko sti či ja je struk tu ra pro me nje-
na usled oste o po ro ze, dok su uzor ci iz nor mal ne ko sti (C) či ni-
li kon trol nu gru pu. Sva ki uzo rak je po mo ću di ja mant skog bo-
re ra i di ja mant skog di ska pa žlji vo iz va đen iz ma se ko sti vi li ca 
ka da ve ra. Uzor ci su eks tra ho va ni iz dva raz li či ta slo ja vi li ca: ba-
zal nog slo ja ko sti, kom pakt ne gra đe, i sunđerastog slo ja u al-
ve o lar nom na stav ku, u bli zi ni fo ra me na men ta le za do nju vi li-
cu. Svi uzor ci su bi li slič ne ve li či ne (1×1×1 cm) i pri zma tič nog 
ob li ka. Uzor ci su raz dvo je ni, izo lo va ni, oči šće ni i raz ma šće ni u 
ace to nu ra di pri pre me za fik sa ci ju i is pi ti va nje [13, 14, 16-19]. 
Po sle su še nja i ču va nja u va ku u mu, uzor ci su me ha nič ki na pra-
še ni u ahat nom ava nu.
Rend gen ski di frak to gra mi eks pe ri men tal nih i kon trol nih 
uzo ra ka sni mlje ni su u di frak to me tru (Crystal lo flex di frac to-
me ter D-500, Si e mens). Rad ni na pon rend gen ske ce vi bio je 35 
kV, a ja či na stru je 20 mA. Na pra še na sup stan ca iz uzo ra ka je 
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po sta vlje na u di frak to me tru, ka ko bi se usta no vi li fa ze i je di nje-
nja iz uzo ra ka ko sti. Di ja gra mi pra ha su sni mlje ni u pod ruč ju 
od 3° do 121°. Sa sva kog di frak to gra ma su od re đe ni in ten zi te ti 
(I) i uglo vi 2Θ. Vred no sti uglo va di frak ci je su iz me re ni pre ma 
jed na či ni α=λ/2sinΘ, gde je α uda lje nost mre žnih rav ni Mi le-
ro vih in dek sa, λ ta la sna du ži na rend gen skog zra če nja, a Θ ugao 
ko ji za kla pa ju rend gen ski zrak i pa ra lel ne rav ni.
REZULTATI
Di frak ci jom rend gen skim zra ci ma iz vr še na je ana li za mi ne ral-
nog sa dr ža ja iz uzo ra ka ko sti. Raz li či tost pa ra me ta ra je pred-
sta vlje na usta no vlje nim po ve ća nji ma vred no sti α-ose, dok se 
vred nost c-ose ni je me nja la.
Re zul ta ti is tra ži va nja su pri ka za ni na ta be li 1 i sli ka ma 1, 2 
i 3. Di frak to gram kon trol nog uzor ka C1 je bio isto ve tan za be le-
že nom di frak to gra mu kon trol nog uzor ka C2. For me kri sta la iz 
is pi ti va nih uzo ra ka su od re đe ne na osno vu po lo ža ja rend gen-
skih tra ka u spek tru mu [15, 16, 20] s po seb nim fo ku som na nji-
ho vu sto i hi o me trij sku struk tu ru (Ta be la 1).
Do bi je ni re zul ta ti su po ka za li da je HAP do mi nant na fa za 
u uzor ci ma C1 i C2, uzi ma ju ći u ob zir či nje ni cu da tra ke ne kih 
dru gih fa za ni su bi le za stu plje ne ili je kon cen tra ci ja ovih fa-
za bi la is pod ni voa de tek ci je. U uzor ku E1 je di nje nja kal ci jum-
mo no fos fat i hi dra ti sa ni kal ci jum-fos fat bi la su pod jed na ko za-
stu plje na, kao i HAP, što je utvr đe no po ve ća njem vred no sti na 
α-osi, po seb no u ra spo nu od 20 do 40. U uzor ku E2 usta no vlje-
ni su HAP i kal ci jum-mo no fos fat, a kal ci jum-mo no fos fat bio je 
za stu pljen već po sle vred no sti 20 na α-osi.
DISKUSIJA
Di frak ci ja je pro ve re na i po u zda na me to da za utvr đi va nje kal ci-
jum-fos fa ta u kri sta li ma i sa sta vu ko sti, ce men ta i tran splan ta-
ti ma za den tal nu, kra ni o fa ci jal nu i or to ped sku pri me nu. Ovom 
me to dom mo gu će je pri ka za ti utvr đen re do sled kri sta la u spek-
tru, što je po tvr đe no i u ovom is tra ži va nju. Di frak ci ja pri ka zu-
je i in ter me di jar na je di nje nja, uko li ko po sto je u kal ci ju mo vim 
kri sta li ma u ko sti, sa do dat kom bi o me trij skih mo le ku la ili bez 
njih [14, 21, 22, 23]. Sto ga je u ovom is tra ži va nju po seb no za-
ni mljiv na laz in ter me di jar nog je di nje nja te tra kal ci jum-fos fa ta 
(Ca4P2O9), na ko je bi tre ba lo obra ti ti pa žnju zbog mo gu ćeg uče-
šća u he mij skim re ak ci ja ma ve zi va nja tran splan ta ta za kost ko ja 
je za hva će na oste o po ro zom. Ovo je di nje nje je he mij ski stvo re no 
pri tem pe ra tu ri od 1200°C, ka da di frak to gram pri ka zu je apa ra-
ci ju te tra kal ci jum-fos fa ta pri sin te ro va nju ve štač kog HAP [24]. 
Osim utvr đi va nja sa sta va ko sti, di frak ci ja po ka zu je kri stal ni sa-
stav i dru gih čvr stih tki va (npr. gle đi i den ti na zu ba) [17], kao 
i di men zi je kri stal ne fa ze u je di nje nji ma kal ci ju ma (HAP) [23, 
25], što ni je bio cilj ovo ga is tra ži va nja.
Re zul ta ti is tra ži va nja su uka za li na raz li čit sa stav čvr stih he-
mij skih je di nje nja u oste o po ro znoj ko sti. S aspek ta he mij ske ana-
li ze, oste o po ro za je pro ces stva ra nja kri sta la raz li či tih po struk-
tu ri od kal ci jum-fos fa ta, od no sno od kal ci jum-mo no fos fa ta i 
HAP. Uzi ma ju ći u ob zir me di jum u okvi ru ko jeg se ovaj pro ces 
raz vi ja, fi zi o lo ški i bi o he mij ski pro ce si bi mo gli bi ti naj od go vor-
ni ji za ova kva sta nja. Osim to ga, zna ča jan fak tor bi mo gle bi ti i 
in ten ziv ne pro me ne pH vred no sti u me di ju mu, bez ne do stat-
ka kal ci ju ma i fos fo ra u ljud skom or ga ni zmu [5, 6]. Me đu tim, 
od nos kal ci ju ma i fos fo ra u he mij skim je di nje nji ma, kao što je 
pri ka za no u ta be li 1, uka zu je na či nje ni cu da ne do sta tak kal ci-
ju ma u fi zi o lo škom me di ju mu mo že ini ci ra ti po nov nu kri sta-
li za ci ju; tač ni je re če no, od HAP, u ko jem je od nos kal ci ju ma i 
fos fo ra 5:3 (i u uzor ku E1 i u uzor ku E2), mo že uslo vi ti do mi na-
ci ju kal ci jum-mo no fos fa ta, je di nje nja u ko jem je od nos kal ci ju-
ma i fos fo ra jed nak (1:1). Na ovaj na čin do la zi do iz me na kri-
sta lo graf ske struk tu re, ali i čvr ste fa ze je di nje nja u me di ju mu. 
Ova kvi na la zi upu ću ju na to da sma nje nje sa dr ža ja kal ci ju ma 
u ras tvo ru ili fi zi o lo škoj sre di ni mo že do ve sti do pre la ska HAP 
u kal ci jum-mo no fos fat ili hi dra ti sa ni kal ci jum-fos fat. Po red 
to ga, stva ra nje sta bil nih kom plek sa kal ci ju ma Ca++ sa dru gim 
neo r gan skim i or gan skim kom po nen ta ma mo glo bi bi ti uzrok 
tran sfor ma ci je HAP u dru ga či je kri stal ne for me.
Či nje ni ca je da is tra ži va nja ova kve vr ste na hu ma nim uzor-
ci ma čvr stog ko šta nog tki va ni su broj na ni u do ma ćoj, ni ti u 
stra noj li te ra tu ri. Me to da di frak ci je rend gen skim zra ci ma je 
sa svim po u zda na u is pi ti va nju kri stal nog sa sta va i neo r gan ske 
struk tu re ko sti u ana li zi čvr stih oral nih i dru gih tki va hu ma-
nog po re kla, od no sno sup stan ci za pri me nu kod lju di [14, 17].
ZAKLJUČAK
Na osno vu rend ge no graf skih ana li za utvr đe no je po sto ja nje kri-
sta lo graf skih for mi kal ci jum-mo no fos fa ta, hi dra ti sa nog kal ci-
jum-fos fa ta i HAP u eks pe ri men tal nim uzor ci ma ko sti za hva-
će ne oste o po ro zom. U uzor ci ma nor mal ne ko sti, bez oste o po-
ro ze, za stu pljen je bio sa mo HAP.
